BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 639884 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CC2)c2OCCCc12 InChI=1S/C19H23ClN4O2/c20-15-10-14(17-13(16(15)21)2-1-9-25-17)19-23-22-18(26-19)11-5-7-24(8-6-11)12-3-4-12/h10-12H,1-9,21H2 JJJUWKQTDCNZKZ-UHFFFAOYSA-N 325557 6-chloro-8-[5-(1-cyclopropyl piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]chroman-5-yl amine::US9636335, 1 5-hydroxytryptamine receptor 4 Human 28.5 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325557&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534480 384580590 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639885 Nc1c(Cl)cc(-c2nnc(CC3CCN(CC3)C3CCC3)o2)c2OCCCc12 InChI=1S/C21H27ClN4O2/c22-17-12-16(20-15(19(17)23)5-2-10-27-20)21-25-24-18(28-21)11-13-6-8-26(9-7-13)14-3-1-4-14/h12-14H,1-11,23H2 ATYKXMXTFKDVKE-UHFFFAOYSA-N 325559 6-Chloro-8-[5-(1-cyclobutyl piperidin-4-ylmethyl)-[1,3,4]oxadiazol-2-yl]-chroman-5-yl amine::US9636335, 2::US9636335, 3 5-hydroxytryptamine receptor 4 Human 47.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325559&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 86724917 384580592 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639886 Nc1c(Cl)cc(-c2nnc(CC3CCN(CC3)C3CCC3)o2)c2OCCCc12 InChI=1S/C21H27ClN4O2/c22-17-12-16(20-15(19(17)23)5-2-10-27-20)21-25-24-18(28-21)11-13-6-8-26(9-7-13)14-3-1-4-14/h12-14H,1-11,23H2 ATYKXMXTFKDVKE-UHFFFAOYSA-N 325559 6-Chloro-8-[5-(1-cyclobutyl piperidin-4-ylmethyl)-[1,3,4]oxadiazol-2-yl]-chroman-5-yl amine::US9636335, 2::US9636335, 3 5-hydroxytryptamine receptor 4 Human 27.5 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325559&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 86724917 384580592 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639887 COCCCN1CCC(CC1)c1nnc(o1)-c1nn(C(C)C)c2ccccc12 InChI=1S/C21H29N5O2/c1-15(2)26-18-8-5-4-7-17(18)19(24-26)21-23-22-20(28-21)16-9-12-25(13-10-16)11-6-14-27-3/h4-5,7-8,15-16H,6,9-14H2,1-3H3 DWTFBJGTRBMHPG-UHFFFAOYSA-N 325561 1-Isopropyl-3-{5-[1-(3-methoxy propyl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole ::US9636335, 4 5-hydroxytryptamine receptor 4 Human 38.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325561&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71508291 384580593 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639888 CC(C)n1nc(-c2nnc(CC3CCN(CC3)C3CCC3)o2)c2ccccc12 InChI=1S/C22H29N5O/c1-15(2)27-19-9-4-3-8-18(19)21(25-27)22-24-23-20(28-22)14-16-10-12-26(13-11-16)17-6-5-7-17/h3-4,8-9,15-17H,5-7,10-14H2,1-2H3 OHUWJCNVHUZNQS-UHFFFAOYSA-N 325563 3-[5-(1-Cyclobutyl-piperidin-4-yl methyl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole ::US9636335, 5 5-hydroxytryptamine receptor 4 Human 18.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325563&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534484 384580595 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639889 Nc1c(Cl)cc(-c2nnc(o2)C2C3CN(CC23)C2CCC2)c2OCCCc12 InChI=1S/C20H23ClN4O2/c21-15-7-12(18-11(17(15)22)5-2-6-26-18)19-23-24-20(27-19)16-13-8-25(9-14(13)16)10-3-1-4-10/h7,10,13-14,16H,1-6,8-9,22H2 NODHOVISMISSPB-UHFFFAOYSA-N 325564 6-Chloro-8-[5-(3-cyclobutyl-3-aza bicyclo[3.1.0]hex-6-yl)-[1,3,4]oxadiazol-2-yl]chroman-5-ylamine::US9636335, 6 5-hydroxytryptamine receptor 4 Human 4.20 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325564&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534777 384580596 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639890 Nc1c2CCOc2c(cc1Cl)-c1nnc(o1)C1CCN(CC1)C1CCOCC1 InChI=1S/C20H25ClN4O3/c21-16-11-15(18-14(17(16)22)5-10-27-18)20-24-23-19(28-20)12-1-6-25(7-2-12)13-3-8-26-9-4-13/h11-13H,1-10,22H2 WSQQNWPPUJLNCD-UHFFFAOYSA-N 325565 5-Chloro-7-{5-[1-(tetrahydro pyran-4-yl) piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-2,3-dihydro benzofuran-4-yl amine::US9636335, 7 5-hydroxytryptamine receptor 4 Human 7.00 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325565&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534781 384580597 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639891 COCCN1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2CCCOc12 InChI=1S/C19H25ClN4O3/c1-25-10-8-24-6-4-12(5-7-24)18-22-23-19(27-18)14-11-15(20)16(21)13-3-2-9-26-17(13)14/h11-12H,2-10,21H2,1H3 GTUCZTYJFXBSTJ-UHFFFAOYSA-N 325566 6-Chloro-8-{5-[1-(2-methoxy-ethyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-chroman-5-ylamine::US9636335, 8 5-hydroxytryptamine receptor 4 Human 15.6 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325566&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534782 384580598 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639892 CC(C)CCN1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2CCCOc12 InChI=1S/C21H29ClN4O2/c1-13(2)5-8-26-9-6-14(7-10-26)20-24-25-21(28-20)16-12-17(22)18(23)15-4-3-11-27-19(15)16/h12-14H,3-11,23H2,1-2H3 MPDKVUXWJYUTJG-UHFFFAOYSA-N 325567 6-Chloro-8-{5-[1-(3-methyl-butyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-chroman-5-ylamine::US9636335, 9 5-hydroxytryptamine receptor 4 Human 2.40 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325567&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534783 384580599 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639893 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC3CCC3)CC2)c2OCCCc12 InChI=1S/C21H27ClN4O2/c22-17-11-16(19-15(18(17)23)5-2-10-27-19)21-25-24-20(28-21)14-6-8-26(9-7-14)12-13-3-1-4-13/h11,13-14H,1-10,12,23H2 ZQCXTCBHKOXIQH-UHFFFAOYSA-N 325568 6-Chloro-8-[5-(1-cyclobutylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 10 5-hydroxytryptamine receptor 4 Human 5.70 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325568&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535363 384580600 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639894 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC3CC3)CC2)c2OCCCc12 InChI=1S/C20H25ClN4O2/c21-16-10-15(18-14(17(16)22)2-1-9-26-18)20-24-23-19(27-20)13-5-7-25(8-6-13)11-12-3-4-12/h10,12-13H,1-9,11,22H2 JRCYLOFVFYSPRU-UHFFFAOYSA-N 325571 6-Chloro-8-[5-(1-cyclopropylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 11 5-hydroxytryptamine receptor 4 Human 10.2 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325571&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535069 384580603 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639895 CC(C)N1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2CCCOc12 InChI=1S/C19H25ClN4O2/c1-11(2)24-7-5-12(6-8-24)18-22-23-19(26-18)14-10-15(20)16(21)13-4-3-9-25-17(13)14/h10-12H,3-9,21H2,1-2H3 JLQUCYAMLNLIIN-UHFFFAOYSA-N 325572 6-Chloro-8-[5-(1-isopropyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 12 5-hydroxytryptamine receptor 4 Human 15.3 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325572&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535070 384580604 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639896 COCCCN1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2CCCOc12 InChI=1S/C20H27ClN4O3/c1-26-10-3-7-25-8-5-13(6-9-25)19-23-24-20(28-19)15-12-16(21)17(22)14-4-2-11-27-18(14)15/h12-13H,2-11,22H2,1H3 PSXYGKNEXSPUHC-UHFFFAOYSA-N 325573 6-Chloro-8-{5-[1-(3-methoxy-propyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-chroman-5-ylamine::US9636335, 13 5-hydroxytryptamine receptor 4 Human 20.4 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325573&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535071 384580605 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639897 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CCC2)c2OCCCc12 InChI=1S/C20H25ClN4O2/c21-16-11-15(18-14(17(16)22)5-2-10-26-18)20-24-23-19(27-20)12-6-8-25(9-7-12)13-3-1-4-13/h11-13H,1-10,22H2 JXDHEGNLQLKXOB-UHFFFAOYSA-N 325574 6-Chloro-8-[5-(1-cyclobutyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 14 5-hydroxytryptamine receptor 4 Human 1.30 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325574&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71534482 384580606 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639898 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC3CCC3)CC2)c2OCCOc12 InChI=1S/C20H25ClN4O3/c21-15-10-14(17-18(16(15)22)27-9-8-26-17)20-24-23-19(28-20)13-4-6-25(7-5-13)11-12-2-1-3-12/h10,12-13H,1-9,11,22H2 IKDXVSAZYALSJB-UHFFFAOYSA-N 325575 6-Chloro-8-[5-(1-cyclobutylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-2,3-dihydro-benzo[1,4]dioxin-5-ylamine::US9636335, 15 5-hydroxytryptamine receptor 4 Human 6.20 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325575&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535073 384580607 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639899 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CCC2)c2OCCOc12 InChI=1S/C19H23ClN4O3/c20-14-10-13(16-17(15(14)21)26-9-8-25-16)19-23-22-18(27-19)11-4-6-24(7-5-11)12-2-1-3-12/h10-12H,1-9,21H2 ABRLWSBQYFGGMJ-UHFFFAOYSA-N 325576 6-Chloro-8-[5-(1-cyclobutyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-2,3-dihydro-benzo[1,4]dioxin-5-ylamine::US9636335, 16 5-hydroxytryptamine receptor 4 Human 13.3 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325576&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535072 384580608 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639900 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CCCC2)c2OCCCc12 InChI=1S/C21H27ClN4O2/c22-17-12-16(19-15(18(17)23)6-3-11-27-19)21-25-24-20(28-21)13-7-9-26(10-8-13)14-4-1-2-5-14/h12-14H,1-11,23H2 UUTZBLPMKADLIH-UHFFFAOYSA-N 325577 6-Chloro-8-[5-(1-cyclopentyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 17 5-hydroxytryptamine receptor 4 Human 2.30 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325577&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535074 384580609 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639901 Nc1c(Cl)cc(-c2nnc(CCN3CCCCC3)o2)c2OCCCc12 InChI=1S/C18H23ClN4O2/c19-14-11-13(17-12(16(14)20)5-4-10-24-17)18-22-21-15(25-18)6-9-23-7-2-1-3-8-23/h11H,1-10,20H2 OGKPCEKQRYMOMQ-UHFFFAOYSA-N 325578 6-Chloro-8-[5-(2-piperidin-1-yl-ethyl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 18 5-hydroxytryptamine receptor 4 Human 53.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325578&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535075 384580610 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639902 CCOC(=O)N1CCC(CC1)N1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2CCCOc12 InChI=1S/C24H32ClN5O4/c1-2-32-24(31)30-11-7-16(8-12-30)29-9-5-15(6-10-29)22-27-28-23(34-22)18-14-19(25)20(26)17-4-3-13-33-21(17)18/h14-16H,2-13,26H2,1H3 XVKQBWCBEZSBDM-UHFFFAOYSA-N 325579 4-[5-(5-Amino-6-chloro-chroman-8-yl)-[1,3,4]oxadiazol-2-yl]-[1,4′]bipiperidinyl-1′-carboxylic acid ethyl ester::US9636335, 19 5-hydroxytryptamine receptor 4 Human 6.80 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325579&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535364 384580611 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639903 Nc1c(Cl)cc(-c2nnc(CCCN3CCCCC3)o2)c2OCCCc12 InChI=1S/C19H25ClN4O2/c20-15-12-14(18-13(17(15)21)6-5-11-25-18)19-23-22-16(26-19)7-4-10-24-8-2-1-3-9-24/h12H,1-11,21H2 MGOCDTKKNFKTFJ-UHFFFAOYSA-N 325580 6-Chloro-8-[5-(3-piperidin-1-yl-propyl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 20 5-hydroxytryptamine receptor 4 Human 104 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325580&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535365 384580612 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639904 Nc1c(Cl)cc(-c2nnc(CC3CCN(CC3)C3CCCC3)o2)c2OCCCc12 InChI=1S/C22H29ClN4O2/c23-18-13-17(21-16(20(18)24)6-3-11-28-21)22-26-25-19(29-22)12-14-7-9-27(10-8-14)15-4-1-2-5-15/h13-15H,1-12,24H2 BLOZJMQLMPZYNA-UHFFFAOYSA-N 325581 6-Chloro-8-[5-(1-cyclopentyl-piperidin-4-ylmethyl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine ::US9636335, 21 5-hydroxytryptamine receptor 4 Human 71.2 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325581&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535367 384580613 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639905 CC(C)N1CC2C(C1)C2c1nnc(o1)-c1cc(Cl)c(N)c2CCCOc12 InChI=1S/C19H23ClN4O2/c1-9(2)24-7-12-13(8-24)15(12)19-23-22-18(26-19)11-6-14(20)16(21)10-4-3-5-25-17(10)11/h6,9,12-13,15H,3-5,7-8,21H2,1-2H3 MRTFYVURPRQOTD-UHFFFAOYSA-N 325582 6-Chloro-8-[5-(3-isopropyl-3-aza-bicyclo[3.1.0]hex-6-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine ::US9636335, 22 5-hydroxytryptamine receptor 4 Human 48.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325582&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 89462966 384580614 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639906 Nc1c(Cl)cc(-c2nnc(o2)C2C3CN(CC4CCC4)CC23)c2OCCCc12 InChI=1S/C21H25ClN4O2/c22-16-7-13(19-12(18(16)23)5-2-6-27-19)20-24-25-21(28-20)17-14-9-26(10-15(14)17)8-11-3-1-4-11/h7,11,14-15,17H,1-6,8-10,23H2 ROVOQJMCLUCNOI-UHFFFAOYSA-N 325583 6-Chloro-8-[5-(3-cyclobutylmethyl-3-aza-bicyclo[3.1.0]hex-6-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine ::US9636335, 23 5-hydroxytryptamine receptor 4 Human 20.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325583&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 89464482 384580615 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639907 Nc1c(Cl)cc(-c2nnc(o2)C2C3CN(CC4CC4)CC23)c2OCCCc12 InChI=1S/C20H23ClN4O2/c21-15-6-12(18-11(17(15)22)2-1-5-26-18)19-23-24-20(27-19)16-13-8-25(9-14(13)16)7-10-3-4-10/h6,10,13-14,16H,1-5,7-9,22H2 PHBJHQYYMLWCFH-UHFFFAOYSA-N 325584 6-Chloro-8-[5-(3-cyclopropylmethyl-3-aza-bicyclo[3.1.0]hex-6-yl)-[1,3,4]oxadiazol-2-yl]-chroman-5-ylamine::US9636335, 24 5-hydroxytryptamine receptor 4 Human 25.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325584&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 90256772 384580616 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639908 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CCOCC2)c2OCCCc12 InChI=1S/C21H27ClN4O3/c22-17-12-16(19-15(18(17)23)2-1-9-28-19)21-25-24-20(29-21)13-3-7-26(8-4-13)14-5-10-27-11-6-14/h12-14H,1-11,23H2 AWPOUNIUIDQWEX-UHFFFAOYSA-N 325585 6-Chloro-8-{5-[1-(tetrahydro-pyran-4-yl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-chroman-5-ylamine ::US9636335, 25 5-hydroxytryptamine receptor 4 Human 5.70 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325585&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535652 384580617 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639909 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC3CCOCC3)CC2)c2OCCCc12 InChI=1S/C22H29ClN4O3/c23-18-12-17(20-16(19(18)24)2-1-9-29-20)22-26-25-21(30-22)15-3-7-27(8-4-15)13-14-5-10-28-11-6-14/h12,14-15H,1-11,13,24H2 JXJPHWRRBPOQSZ-UHFFFAOYSA-N 325586 6-Chloro-8-{5-[1-(tetrahydro-pyran-4-ylmethyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-chroman-5-ylamine ::US9636335, 26 5-hydroxytryptamine receptor 4 Human 18.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325586&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535654 384580618 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639910 Nc1c2CCOc2c(cc1Cl)-c1nnc(o1)C1CCN(CC1)C1CC1 InChI=1S/C18H21ClN4O2/c19-14-9-13(16-12(15(14)20)5-8-24-16)18-22-21-17(25-18)10-3-6-23(7-4-10)11-1-2-11/h9-11H,1-8,20H2 WLEYGOLXGVMJSQ-UHFFFAOYSA-N 325587 5-Chloro-7-[5-(1-cyclopropyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-2,3-dihydro-benzofuran-4-ylamine ::US9636335, 27 5-hydroxytryptamine receptor 4 Human 60.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325587&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535656 384580619 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639911 Nc1c2CCOc2c(cc1Cl)-c1nnc(o1)C1CCN(CC1)C1CCC1 InChI=1S/C19H23ClN4O2/c20-15-10-14(17-13(16(15)21)6-9-25-17)19-23-22-18(26-19)11-4-7-24(8-5-11)12-2-1-3-12/h10-12H,1-9,21H2 LGPMVAQCGCVPMH-UHFFFAOYSA-N 325588 5-Chloro-7-[5-(1-cyclobutyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-2,3-dihydro-benzofuran-4-ylamine ::US9636335, 28 5-hydroxytryptamine receptor 4 Human 10.00 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325588&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535658 384580620 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639912 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CC2)c2OCCOc12 InChI=1S/C18H21ClN4O3/c19-13-9-12(15-16(14(13)20)25-8-7-24-15)18-22-21-17(26-18)10-3-5-23(6-4-10)11-1-2-11/h9-11H,1-8,20H2 ZTSMTBKBUZLHPT-UHFFFAOYSA-N 325589 6-Chloro-8-[5-(1-cyclopropyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-2,3-dihydro-benzo[1,4]dioxin-5-ylamine::US9636335, 29 5-hydroxytryptamine receptor 4 Human 21.5 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325589&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535660 384580621 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639913 Nc1c(Cl)cc(-c2nnc(o2)C2CCN(CC2)C2CCOCC2)c2OCCOc12 InChI=1S/C20H25ClN4O4/c21-15-11-14(17-18(16(15)22)28-10-9-27-17)20-24-23-19(29-20)12-1-5-25(6-2-12)13-3-7-26-8-4-13/h11-13H,1-10,22H2 VJFMISREOFIVKK-UHFFFAOYSA-N 325590 6-Chloro-8-{5-[1-(tetrahydro-pyran-4-yl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-2,3-dihydro-benzo[1,4]dioxin-5-ylamine::US9636335, 30 5-hydroxytryptamine receptor 4 Human 7.30 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325590&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535940 384580622 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639914 COCCCN1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2OCCOc12 InChI=1S/C19H25ClN4O4/c1-25-8-2-5-24-6-3-12(4-7-24)18-22-23-19(28-18)13-11-14(20)15(21)17-16(13)26-9-10-27-17/h11-12H,2-10,21H2,1H3 ANPYIJMLIIVTPH-UHFFFAOYSA-N 325591 6-Chloro-8-{5-[1-(3-methoxy-propyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-2,3-dihydro-benzo[1,4]dioxin-5-ylamine::US9636335, 31 5-hydroxytryptamine receptor 4 Human 16.9 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325591&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535942 384580623 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639915 Nc1c2CCOc2c(cc1Cl)-c1nnc(o1)C1CCN(CC2CCOCC2)CC1 InChI=1S/C21H27ClN4O3/c22-17-11-16(19-15(18(17)23)5-10-28-19)21-25-24-20(29-21)14-1-6-26(7-2-14)12-13-3-8-27-9-4-13/h11,13-14H,1-10,12,23H2 QJELFRKMGRTYJM-UHFFFAOYSA-N 325592 5-Chloro-7-{5-[1-(tetrahydro-pyran-4-ylmethyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-2,3-dihydro-benzofuran-4-ylamine::US9636335, 33 5-hydroxytryptamine receptor 4 Human 21.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325592&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71535946 384580624 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639916 CCOC(=O)N1CCC(CC1)N1CCC(CC1)c1nnc(o1)-c1cc(Cl)c(N)c2CCOc12 InChI=1S/C23H30ClN5O4/c1-2-31-23(30)29-10-5-15(6-11-29)28-8-3-14(4-9-28)21-26-27-22(33-21)17-13-18(24)19(25)16-7-12-32-20(16)17/h13-15H,2-12,25H2,1H3 HBCDFNHYNGXVCU-UHFFFAOYSA-N 325593 4-[5-(4-Amino-5-chloro-2,3-dihydro-benzofuran-7-yl)-[1,3,4]oxadiazol-2-yl]-[1,4′]bipiperidinyl-1′-carboxylicacid ethyl ester::US9636335, 34 5-hydroxytryptamine receptor 4 Human 5.00 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325593&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536467 384580625 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639917 CC(C)n1nc(-c2nnc(o2)C2CCN(CC3CCC3)CC2)c2ccccc12 InChI=1S/C22H29N5O/c1-15(2)27-19-9-4-3-8-18(19)20(25-27)22-24-23-21(28-22)17-10-12-26(13-11-17)14-16-6-5-7-16/h3-4,8-9,15-17H,5-7,10-14H2,1-2H3 LVIZUKFRUKBLEZ-UHFFFAOYSA-N 325594 3-[5-(1-Cyclobutylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole::US9636335, 35 5-hydroxytryptamine receptor 4 Human 169 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325594&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536206 384580626 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639918 COCCN1CCC(CC1)c1nnc(o1)-c1nn(C(C)C)c2ccccc12 InChI=1S/C20H27N5O2/c1-14(2)25-17-7-5-4-6-16(17)18(23-25)20-22-21-19(27-20)15-8-10-24(11-9-15)12-13-26-3/h4-7,14-15H,8-13H2,1-3H3 OBQZRZCCOLRCKJ-UHFFFAOYSA-N 325595 1-Isopropyl-3-{5-[1-(2-methoxy-ethyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole::US9636335, 36 5-hydroxytryptamine receptor 4 Human 143 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325595&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536207 384580627 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639919 CC(C)n1nc(-c2nnc(o2)C2CCN(CC2)C2CCC2)c2ccccc12 InChI=1S/C21H27N5O/c1-14(2)26-18-9-4-3-8-17(18)19(24-26)21-23-22-20(27-21)15-10-12-25(13-11-15)16-6-5-7-16/h3-4,8-9,14-16H,5-7,10-13H2,1-2H3 SVIPNSAZTOJNPK-UHFFFAOYSA-N 325596 3-[5-(1-Cyclobutyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole::US9636335, 37 5-hydroxytryptamine receptor 4 Human 127 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325596&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536208 384580628 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639920 CC(C)N1CCC(CC1)c1nnc(o1)-c1nn(C(C)C)c2ccccc12 InChI=1S/C20H27N5O/c1-13(2)24-11-9-15(10-12-24)19-21-22-20(26-19)18-16-7-5-6-8-17(16)25(23-18)14(3)4/h5-8,13-15H,9-12H2,1-4H3 HUYJRMFAFYNTRY-UHFFFAOYSA-N 325597 1-Isopropyl-3-[5-(1-isopropyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1H-indazole::US9636335, 38 5-hydroxytryptamine receptor 4 Human 23.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325597&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536209 384580629 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639921 CC(C)n1nc(-c2nnc(o2)C2CCN(CC3CC3)CC2)c2ccccc12 InChI=1S/C21H27N5O/c1-14(2)26-18-6-4-3-5-17(18)19(24-26)21-23-22-20(27-21)16-9-11-25(12-10-16)13-15-7-8-15/h3-6,14-16H,7-13H2,1-2H3 QZTKHUMXLKMPFW-UHFFFAOYSA-N 325598 3-[5-(1-Cyclopropylmethyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole::US9636335, 39 5-hydroxytryptamine receptor 4 Human 66.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325598&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536210 384580630 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639922 CC(C)CCN1CCC(CC1)c1nnc(o1)-c1nn(C(C)C)c2ccccc12 InChI=1S/C22H31N5O/c1-15(2)9-12-26-13-10-17(11-14-26)21-23-24-22(28-21)20-18-7-5-6-8-19(18)27(25-20)16(3)4/h5-8,15-17H,9-14H2,1-4H3 MTHISTWFYBPNHH-UHFFFAOYSA-N 325599 1-Isopropyl-3-{5-[1-(3-methyl-butyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole::US9636335, 40 5-hydroxytryptamine receptor 4 Human 116 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325599&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536211 384580631 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639923 CC(C)n1nc(-c2nnc(o2)C2CCN(CC2)C2CC2)c2ccccc12 InChI=1S/C20H25N5O/c1-13(2)25-17-6-4-3-5-16(17)18(23-25)20-22-21-19(26-20)14-9-11-24(12-10-14)15-7-8-15/h3-6,13-15H,7-12H2,1-2H3 JTRVNNILEYAXKB-UHFFFAOYSA-N 325600 3-[5-(1-Cyclopropyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole::US9636335, 41 5-hydroxytryptamine receptor 4 Human 199 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325600&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536212 384580632 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639924 CC(C)n1nc(-c2nnc(o2)C2CCN(CC2)C2CCCC2)c2ccccc12 InChI=1S/C22H29N5O/c1-15(2)27-19-10-6-5-9-18(19)20(25-27)22-24-23-21(28-22)16-11-13-26(14-12-16)17-7-3-4-8-17/h5-6,9-10,15-17H,3-4,7-8,11-14H2,1-2H3 ZCLZOGZSLISYIY-UHFFFAOYSA-N 325601 3-[5-(1-Cyclopentyl-piperidin-4-yl)-[1,3,4]oxadiazol-2-yl]-1-isopropyl-1H-indazole::US9636335, 42 5-hydroxytryptamine receptor 4 Human 72.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325601&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536468 384580633 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639925 CC(C)n1nc(-c2nnc(o2)C2CCN(CC3CCOCC3)CC2)c2ccccc12 InChI=1S/C23H31N5O2/c1-16(2)28-20-6-4-3-5-19(20)21(26-28)23-25-24-22(30-23)18-7-11-27(12-8-18)15-17-9-13-29-14-10-17/h3-6,16-18H,7-15H2,1-2H3 BVHLNQMKXPIQOB-UHFFFAOYSA-N 325602 1-Isopropyl-3-{5-[1-(tetrahydro-pyran-4-ylmethyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole ::US9636335, 47 5-hydroxytryptamine receptor 4 Human 84.5 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325602&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71537032 384580634 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639926 CC(C)n1nc(-c2nnc(o2)C2CCN(CC2)C2CCOCC2)c2ccccc12 InChI=1S/C22H29N5O2/c1-15(2)27-19-6-4-3-5-18(19)20(25-27)22-24-23-21(29-22)16-7-11-26(12-8-16)17-9-13-28-14-10-17/h3-6,15-17H,7-14H2,1-2H3 KHBGKYWBBOIOEW-UHFFFAOYSA-N 325603 1-Isopropyl-3-{5-[1-(tetrahydro-pyran-4-yl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-1H-indazole ::US9636335, 48 5-hydroxytryptamine receptor 4 Human 54.0 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325603&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536747 384580635 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6 639927 CC(C)n1nc(-c2nnc(CCN3CCCCC3)o2)c2ccccc12 InChI=1S/C19H25N5O/c1-14(2)24-16-9-5-4-8-15(16)18(22-24)19-21-20-17(25-19)10-13-23-11-6-3-7-12-23/h4-5,8-9,14H,3,6-7,10-13H2,1-2H3 QSXVQVWBNVEVSZ-UHFFFAOYSA-N 325604 1-Isopropyl-3-[5-(2-piperidin-1-yl-ethyl)-[1,3,4]oxadiazol-2-yl]-1H-indazole ::US9636335, 49 5-hydroxytryptamine receptor 4 Human 181 US Patent 10.7270/Q2PG1TTQ aid1796763 US9636335 Nirogi, R; Mohammed, AR; Yarlagadda, S; Ravella, SR; Shinde, AK; Kambhampati, R; Roayapalley, PK; Jayarajan, P; Bhyrapuneni, G; Patnala, SM; Ravula, J; Jasti, V 5/2/2017 5/29/2019 Suven Life Sciences Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=325604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8334&target=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=325604&enzyme=5-hydroxytryptamine+receptor+4&column=ki&startPg=0&Increment=50&submit=Search 71536749 384580636 1 MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEKRKFNQNSNSTYCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAHQIQMLQRAGASSESRPQSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDPFIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYRRPSILGQTVPCSTTTINGSTHVLRDAVECGGQWESQCHPPATSPLVAAQPSDT 7XT8,7XT9,7XTA 5-hydroxytryptamine receptor 4 5HT4R_HUMAN Q13639 C4WYH4 Q546Q1 Q684M0 Q712M9 Q96KH9 Q96KI0 Q9H199 Q9NY73 Q9UBM6 Q9UBT4 Q9UE22 Q9UE23 Q9UQR6